APPENDIX A.
Drugs included in prescribing data from primary care trusts
BNF code | Group of drug |
---|---|
2 | Cardiovascular system |
2.1.1 | Cardiac glycosides |
2.2 | Diuretics |
2.4 | Beta-adrenoceptor blocking drugs |
2.5.5.1 | Angiotensin-converting enzyme inhibitors |
2.5.5.2 | Angiotensin-II receptor antagonists |
2.6.1 | Nitrates |
2.6.2 | Calcium-channel blockers |
2.9 | Aspirin |
2.9 | Clopidogrel |
2.9 | Antiplatelet drugs—aspirin and clopidogrel only |
2.12 | Atorvastatin |
2.12 | Cerivastatin |
2.12 | Fluvastatin sodium |
2.12 | Lovastatin |
2.12 | Pravastatin sodium |
2.12 | Simvastatin |
2.12 | Lipid-lowering drugs —statins only |
3 | Respiratory system |
3.1.1.1 | Selective beta(2)-agonists |
3.1.2 | Antimuscarinic bronchodilators |
3.1.3 | Theophylline |
3.1.4 | Compound bronchodilator preparations |
3.2 | Corticosteroids (respiratory) |
3.3.1 | Cromoglycate and related therapy |
3.3.2 | Leukotriene receptor antagonists |
6.1 | Drugs used in diabetes |
6.1.1.1 | Short-acting insulins |
6.1.1.2 | Intermediate and long-acting insulins |
6.1.2 | Oral antidiabetic drugs |
6.1.2.1 | Sulphonylureas |
6.1.2.2 | Biguanides |
6.1.2.3 | Other antidiabetics |
6.1.6 | Screening and monitoring agents |
BNF, British National Formulary